Han Fang, Ozawa Hitoshi, Matsuda Ken-ichi, Nishi Mayumi, Kawata Mitsuhiro
Department of Anatomy and Neurobiology, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, Kyoto 602-8566, Japan.
Neurosci Res. 2005 Apr;51(4):371-81. doi: 10.1016/j.neures.2004.12.013. Epub 2005 Jan 20.
We investigated the distribution and colocalization pattern of the two corticosteroid receptors, mineralocorticoid receptor (MR) and glucocorticoid receptor (GR), in the hippocampus and hypothalamus, the main target regions of corticosterone in the rat brain, using double immunofluorescence histochemistry in conjunction with specific polyclonal antibodies against MR and GR. In the hippocampus, MR- and GR-immunoreactivity (ir) were colocalized in CA1 and CA2 pyramidal neurons and granule cells of the dentate gyrus, while only MR-ir was seen in the CA3 pyramidal neurons. Colocalization of MR- and GR-ir was also observed in the parvocellular region, but not in the magnocellular region of the paraventricular nucleus (PVN). Subcellular distribution of MR-ir was more cytoplasmic in comparison with that of GR-ir, while the ratio of cytoplasmic to nuclear distribution of these receptors was different among the regions. After adrenalectomy (ADX), the distribution pattern of both receptors was changed to cytoplasmic, although the degree of the change of distribution was different among each region. Replacement of corticosterone after ADX recovered the distribution pattern to that of the sham-operated animals. These results suggest that the balance of MR and GR in the cell underlies the potential regulation of corticosteroid through the hippocampus and hypothalamus.
我们运用双重免疫荧光组织化学技术,结合针对盐皮质激素受体(MR)和糖皮质激素受体(GR)的特异性多克隆抗体,研究了大鼠脑中皮质酮的主要靶区域——海马体和下丘脑内这两种皮质类固醇受体的分布及共定位模式。在海马体中,MR免疫反应性(ir)和GR免疫反应性在CA1和CA2锥体神经元以及齿状回颗粒细胞中共定位,而在CA3锥体神经元中仅可见MR免疫反应性。在室旁核(PVN)的小细胞区域也观察到了MR免疫反应性和GR免疫反应性的共定位,但在大细胞区域未观察到。与GR免疫反应性相比,MR免疫反应性的亚细胞分布更多位于细胞质中,并且这些受体在不同区域的细胞质与细胞核分布比例有所不同。肾上腺切除(ADX)后,尽管每个区域分布变化的程度不同,但两种受体的分布模式均变为细胞质分布。ADX后补充皮质酮可使分布模式恢复到假手术动物的状态。这些结果表明,细胞内MR和GR的平衡是通过海马体和下丘脑对皮质类固醇进行潜在调节的基础。